Vanrx worked with The Linus Group to interview dozens of pharmaceutical manufacturing leaders about how downstream aseptic processing is changing.
We asked these leaders about:
- What strategies are being used to cope with increased drug product complexity and competitive pressures?
- How to balance needs and risk when selecting production technologies?
- What benefits can be expected from selecting new production technologies in aseptic filling?
The resulting data can help guide drug product operational strategies. In light of the post-COVID landscape, proper planning is essential.
Speakers
John Harmer, Vice President, Marketing, Vanrx Pharmasystems
After more than 30 years in the pharmaceutical industry, Harmer has experience in just about every aspect of drug development and manufacturing. In addition to aseptic filling, he has worked in API production and process development, device development, clinical trial logistics, and regulatory submissions for novel therapeutics. John understands the timelines and challenges of the drug development process and is a valuable technical resource for Vanrx’s customers.
Message Presenter
Hamid Ghanadan, Founder, The Linus Group
Hamid Ghanadan has dedicated his career to redefining the way we communicate to the life science and healthcare industries. As a biochemist turned strategist, he has a unique understanding of the thought processes of a technical mind. Using these observations, Ghanadan advocates for healthcare leaders to develop strategies that reflect the way a scientist or clinician thinks.
Message PresenterWho Should Attend?
In this webinar, participants will hear from:
- Manufacturing leaders developing strategies for making sterile injectable drug products, including mAbs, gene therapies, mRNA and personalized medicines.
- Plant operations leaders and process engineers working on aseptic filling for injectables.
- Executives considering entering the filling space or expanding their aseptic filling operations.
What You Will Learn
In this webinar, participants will:
- Explore data about aseptic filling and technology adoption from experts in the biopharmaceutical industry, including executives, manufacturing and process development leaders
- Learn how to balance aseptic filling needs and risks in bringing drug products through the clinic and into commercialization.
- Learn how standardization around closed robotic systems for aseptic filling creates a ‘virtuous cycle’ of reducing risk, eliminating errors and bringing costs down
- Hear examples of how these strategies are being used to succeed
Xtalks Partner
Vanrx Pharmasystems
Vanrx Pharmasystems makes the most technologically advanced sterile filling solutions for the pharmaceutical industry. Vanrx fill-finish machines use robotics, machine vision and gloveless isolator technologies to automate the packaging of injectable drugs into vials, syringes, or cartridges. The company was founded by pharmaceutical industry veterans to create the systems needed to make the next generation of innovative therapies.
Related Webinars
How Aseptic Filling Can Make Up Lost Time in a Drug Development Program
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account